• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用癌症进展相关特征预测临床结果。

Predicting clinical outcomes using cancer progression associated signatures.

作者信息

Mamrot Jared, Hall Nathan E, Lindley Robyn A

机构信息

GMDx Group Ltd, Melbourne, Victoria, Australia.

Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia.

出版信息

Oncotarget. 2021 Apr 13;12(8):845-858. doi: 10.18632/oncotarget.27934.

DOI:10.18632/oncotarget.27934
PMID:33889305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8057277/
Abstract

Somatic mutation signatures are an informative facet of cancer aetiology, however they are rarely useful for predicting patient outcome. The aim of this study is to evaluate the utility of a panel of 142 mutation-signature-associated metrics (P142) for predicting cancer progression in patients from a 'TCGA PanCancer Atlas' cohort. The P142 metrics are comprised of AID/APOBEC and ADAR deaminase associated SNVs analyzed for codon context, strand bias, and transitions/transversions. TCGA tumor-normal mutation data was obtained for 10,437 patients, representing 31 of the most prevalent forms of cancer. Stratified random sampling was used to split patients into training, tuning and validation cohorts for each cancer type. Cancer specific machine learning (XGBoost) models were built using the output from the P142 panel to predict patient Progression Free Survival (PFS) status as either "High PFS" or "Low PFS". Predictive performance of each model was evaluated using the validation cohort. Models accurately predicted PFS status for several cancer types, including adrenocortical carcinoma, glioma, mesothelioma, and sarcoma. In conclusion, the P142 panel of metrics successfully predicted cancer progression status in patients with some, but not all cancer types analyzed. These results pave the way for future studies on cancer progression associated signatures.

摘要

体细胞突变特征是癌症病因学中一个具有参考价值的方面,然而它们很少能用于预测患者的预后。本研究的目的是评估一组142个与突变特征相关的指标(P142)在预测“TCGA泛癌图谱”队列患者癌症进展方面的效用。P142指标由针对密码子上下文、链偏好以及转换/颠换分析的AID/APOBEC和ADAR脱氨酶相关的单核苷酸变异组成。获取了10437名患者的TCGA肿瘤-正常组织突变数据,这些患者代表了31种最常见的癌症形式。采用分层随机抽样将患者按癌症类型分为训练、调整和验证队列。使用P142指标组的输出构建癌症特异性机器学习(XGBoost)模型,以预测患者的无进展生存期(PFS)状态为“高PFS”或“低PFS”。使用验证队列评估每个模型的预测性能。模型准确预测了几种癌症类型的PFS状态,包括肾上腺皮质癌、胶质瘤、间皮瘤和肉瘤。总之,P142指标组成功预测了部分(但并非所有)所分析癌症类型患者的癌症进展状态。这些结果为未来关于癌症进展相关特征的研究铺平了道路。

相似文献

1
Predicting clinical outcomes using cancer progression associated signatures.利用癌症进展相关特征预测临床结果。
Oncotarget. 2021 Apr 13;12(8):845-858. doi: 10.18632/oncotarget.27934.
2
Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.开发和验证一种机器学习模型,以探索 IV 期 EGFR 突变阳性非小细胞肺癌患者对酪氨酸激酶抑制剂的反应。
JAMA Netw Open. 2020 Dec 1;3(12):e2030442. doi: 10.1001/jamanetworkopen.2020.30442.
3
Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer.用于预测晚期非小细胞肺癌患者预后的机器学习与随机肿瘤生长模型
JCO Clin Cancer Inform. 2019 Sep;3:1-11. doi: 10.1200/CCI.19.00046.
4
Association between targeted somatic mutation (TSM) signatures and HGS-OvCa progression.靶向体细胞突变(TSM)特征与高级别浆液性卵巢癌(HGS-OvCa)进展之间的关联。
Cancer Med. 2016 Sep;5(9):2629-40. doi: 10.1002/cam4.825. Epub 2016 Aug 3.
5
Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.免疫与癌症中的体细胞超突变:对链偏向性和密码子上下文突变特征的批判性分析。
DNA Repair (Amst). 2016 Sep;45:1-24. doi: 10.1016/j.dnarep.2016.07.001. Epub 2016 Jul 10.
6
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.一种基于放射组学的方法来评估肿瘤浸润 CD8 细胞与抗 PD-1 或抗 PD-L1 免疫治疗反应的关系:一项影像学生物标志物、回顾性多队列研究。
Lancet Oncol. 2018 Sep;19(9):1180-1191. doi: 10.1016/S1470-2045(18)30413-3. Epub 2018 Aug 14.
7
PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.PreMSIm:一个用于通过癌症中基因面板的表达谱预测微卫星不稳定性的R包。
Comput Struct Biotechnol J. 2020 Mar 19;18:668-675. doi: 10.1016/j.csbj.2020.03.007. eCollection 2020.
8
APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.载脂蛋白B mRNA编辑酶催化多肽样蛋白(APOBEC)和腺苷脱氨酶(ADAR)可能导致在线孟德尔遗传数据库(OMIM)中整理的许多单核苷酸多态性。
Mutat Res. 2018 Jul;810:33-38. doi: 10.1016/j.mrfmmm.2018.03.008. Epub 2018 Jun 22.
9
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.一种基于放射组学的方法,用于预测接受立体定向体部放射治疗的早期非小细胞肺癌患者的淋巴结复发和疾病特异性生存。
Strahlenther Onkol. 2020 Oct;196(10):922-931. doi: 10.1007/s00066-019-01542-6. Epub 2019 Nov 13.
10
Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.基于术前磁共振成像放射组学的signature 模型:预测早期乳腺癌患者腋窝淋巴结转移和无病生存的研究
JAMA Netw Open. 2020 Dec 1;3(12):e2028086. doi: 10.1001/jamanetworkopen.2020.28086.

引用本文的文献

1
Deaminase-Driven Reverse Transcription Mutagenesis in Oncogenesis: Critical Analysis of Transcriptional Strand Asymmetries of Single Base Substitution Signatures.脱氨酶驱动的逆转录诱变在肿瘤发生中的作用:单碱基替换特征转录链不对称性的批判性分析
Int J Mol Sci. 2025 Jan 24;26(3):989. doi: 10.3390/ijms26030989.

本文引用的文献

1
Interactions of APOBEC3s with DNA and RNA.APOBEC3 与 DNA 和 RNA 的相互作用。
Curr Opin Struct Biol. 2021 Apr;67:195-204. doi: 10.1016/j.sbi.2020.12.004. Epub 2021 Jan 22.
2
Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors.非传染性疾病(NCDs)及其风险因素的管理与预防策略
Front Public Health. 2020 Nov 26;8:574111. doi: 10.3389/fpubh.2020.574111. eCollection 2020.
3
Common germline-somatic variant interactions in advanced urothelial cancer.高级尿路上皮癌中常见的种系-体细胞变异相互作用。
Nat Commun. 2020 Dec 3;11(1):6195. doi: 10.1038/s41467-020-19971-8.
4
The trajectory of intrahelical lesion recognition and extrusion by the human 8-oxoguanine DNA glycosylase.人源 8-氧鸟嘌呤 DNA 糖基化酶识别和挤出螺旋内损伤的轨迹。
Nat Commun. 2020 Sep 7;11(1):4437. doi: 10.1038/s41467-020-18290-2.
5
APOBEC3A catalyzes mutation and drives carcinogenesis in vivo.APOBEC3A 在体内催化突变并驱动致癌作用。
J Exp Med. 2020 Dec 7;217(12). doi: 10.1084/jem.20200261.
6
Molecular origins of APOBEC-associated mutations in cancer.癌症中 APOBEC 相关突变的分子起源。
DNA Repair (Amst). 2020 Oct;94:102905. doi: 10.1016/j.dnarep.2020.102905. Epub 2020 Jul 6.
7
Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression.东亚非吸烟肺癌的蛋白质基因组学揭示了发病机制和进展的分子特征。
Cell. 2020 Jul 9;182(1):226-244.e17. doi: 10.1016/j.cell.2020.06.012.
8
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1.肿瘤突变负荷可预测异柠檬酸脱氢酶1(IDH1)突变型低级别胶质瘤患者的生存情况。
Neurooncol Adv. 2020 Mar 27;2(1):vdaa042. doi: 10.1093/noajnl/vdaa042. eCollection 2020 Jan-Dec.
9
Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition.腺苷脱氨酶作用于 RNA 的不对称二聚化促进底物识别。
Nucleic Acids Res. 2020 Aug 20;48(14):7958-7972. doi: 10.1093/nar/gkaa532.
10
Deep learning-based survival prediction for multiple cancer types using histopathology images.基于深度学习的多癌症类型生存预测:使用组织病理学图像。
PLoS One. 2020 Jun 17;15(6):e0233678. doi: 10.1371/journal.pone.0233678. eCollection 2020.